These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37624820)

  • 41. Management of lipid-lowering therapy in patients with cardiovascular events in the UK: a retrospective cohort study.
    Danese MD; Gleeson M; Kutikova L; Griffiths RI; Khunti K; Seshasai SRK; Ray KK
    BMJ Open; 2017 May; 7(5):e013851. PubMed ID: 28495810
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of body mass index and waist circumference on the cardiovascular risk and all-cause death in a general population: data from the PAMELA study.
    Bombelli M; Facchetti R; Fodri D; Brambilla G; Sega R; Grassi G; Mancia G
    Nutr Metab Cardiovasc Dis; 2013 Jul; 23(7):650-6. PubMed ID: 22633796
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of risk factor reduction and tolerability of a full-dose polypill (with potassium) versus low-dose polypill (polycap) in individuals at high risk of cardiovascular diseases: the Second Indian Polycap Study (TIPS-2) investigators.
    Yusuf S; Pais P; Sigamani A; Xavier D; Afzal R; Gao P; Teo KK
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):463-71. PubMed ID: 22787067
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Baseline albuminuria predicts the efficacy of blood pressure-lowering drugs in preventing cardiovascular events.
    Boersma C; Postma MJ; Visser ST; Atthobari J; de Jong PE; de Jong-van den Berg LT; Gansevoort RT;
    Br J Clin Pharmacol; 2008 May; 65(5):723-32. PubMed ID: 18241288
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The obesity paradox, weight loss, and coronary disease.
    Lavie CJ; Milani RV; Artham SM; Patel DA; Ventura HO
    Am J Med; 2009 Dec; 122(12):1106-14. PubMed ID: 19682667
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Achievement of the low-density lipoprotein cholesterol goal among patients with dyslipidemia in South Korea.
    Kim S; Han S; Rane PP; Qian Y; Zhao Z; Suh HS
    PLoS One; 2020; 15(1):e0228472. PubMed ID: 31999714
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cost-effectiveness and public health benefit of secondary cardiovascular disease prevention from improved adherence using a polypill in the UK.
    Becerra V; Gracia A; Desai K; Abogunrin S; Brand S; Chapman R; García Alonso F; Fuster V; Sanz G
    BMJ Open; 2015 May; 5(5):e007111. PubMed ID: 25991449
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The use of the CNIC-Polypill in real-life clinical practice: opportunities and challenges in patients at very high risk of atherosclerotic cardiovascular disease - expert panel meeting report.
    Grigorian-Shamagian L; Coca A; Morais J; Perez-Martinez P;
    BMC Proc; 2023 Aug; 17(Suppl 8):20. PubMed ID: 37587509
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vitamin D is negatively associated with triglyceride in overweight/obese patients with type 2 diabetes.
    Gong T; Di H; Han X; Hu X; Liu C; Chen G
    Endocrine; 2022 May; 76(2):304-311. PubMed ID: 35247144
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Practical Decision Algorithms for the Use of the Cardiovascular Polypill in Secondary Prevention in Europe.
    Grigorian-Shamagian L; Edel K; Esteve-Pastor MA; Aceña Á; Silva C; Delgado-Silva J; Ntaios G; Demerouti E; Brotons C
    Front Cardiovasc Med; 2021; 8():663361. PubMed ID: 34504874
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Women show worse control of type 2 diabetes and cardiovascular disease risk factors than men: results from the MIND.IT Study Group of the Italian Society of Diabetology.
    Franzini L; Ardigò D; Cavalot F; Miccoli R; Rivellese AA; Trovati M; Zavaroni I; Vaccaro O
    Nutr Metab Cardiovasc Dis; 2013 Mar; 23(3):235-41. PubMed ID: 22397873
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relation between baseline LDL-cholesterol and cardiovascular outcomes in high cardiovascular risk hypertensive patients: A post-hoc SPRINT data analysis.
    Nguyen LS; Procopi N; Salem JE; Squara P; Funck-Brentano C
    Int J Cardiol; 2019 Jul; 286():159-161. PubMed ID: 30685099
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiovascular risk factors in overweight and obese Chinese children: a comparison of weight-for-height index and BMI as the screening criterion.
    Zhang CX; Tse LA; Deng XQ; Jiang ZQ
    Eur J Nutr; 2008 Aug; 47(5):244-50. PubMed ID: 18587680
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 2017 Taiwan lipid guidelines for high risk patients.
    Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI;
    J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interventions for weight loss in people with chronic kidney disease who are overweight or obese.
    Conley MM; McFarlane CM; Johnson DW; Kelly JT; Campbell KL; MacLaughlin HL
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013119. PubMed ID: 33782940
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Accuracy of blood pressure measurement across BMI categories using the OptiBP™ mobile application.
    Caillat M; Degott J; Wuerzner A; Proençain M; Bonnier G; Knebel JF; Stoll C; Christen U; Durgnat V; Hofmann G; Burnier M; Wuerzner G; Schoettker P
    Blood Press; 2022 Dec; 31(1):288-296. PubMed ID: 36266938
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term achievement of the therapeutic objectives of lipid-lowering agents in primary prevention patients and cardiovascular outcomes: an observational study.
    Van Ganse E; Souchet T; Laforest L; Moulin P; Bertrand M; Le Jeunne P; Chretin S; Yin D; Alemao E; de Pouvourville G
    Atherosclerosis; 2006 Mar; 185(1):58-64. PubMed ID: 16038912
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A polypill for all? Critical review of the polypill literature for primary prevention of cardiovascular disease and stroke.
    Carey KM; Comee MR; Donovan JL; Kanaan AO
    Ann Pharmacother; 2012 May; 46(5):688-95. PubMed ID: 22570437
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Polypill with or without Aspirin in Persons without Cardiovascular Disease.
    Yusuf S; Joseph P; Dans A; Gao P; Teo K; Xavier D; López-Jaramillo P; Yusoff K; Santoso A; Gamra H; Talukder S; Christou C; Girish P; Yeates K; Xavier F; Dagenais G; Rocha C; McCready T; Tyrwhitt J; Bosch J; Pais P;
    N Engl J Med; 2021 Jan; 384(3):216-228. PubMed ID: 33186492
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.